Unique ID issued by UMIN | UMIN000053495 |
---|---|
Receipt number | R000061053 |
Scientific Title | Evaluation of health function of cooked rice with emulsified formulation: Single-arm open study |
Date of disclosure of the study information | 2024/02/03 |
Last modified on | 2024/07/31 09:16:32 |
Evaluation of health function of cooked rice with emulsified formulation: Single-arm open study
Evaluation of health function of cooked rice with emulsified formulation: Single-arm open study
Evaluation of health function of cooked rice with emulsified formulation: Single-arm open study
Evaluation of health function of cooked rice with emulsified formulation: Single-arm open study
Japan |
Healthy male adults
Adult |
Others
NO
Accessing the glycemic response to the rice with emulsified formulation including rice bran oil
Efficacy
Blood glucose and insulin levels
Blood triglyceride level, Blood total GLP-1 and GIP levels, Anthropometric tests, blood biochemical tests, and hematologic tests
<Exploratory outcomes>
Brief-type self-administrated diet history questionnaire (BDHQ), Eating behavior questionnaire Continuous glucose monitor, Sensory questionnaire, Body Composition analysis by DEXA method
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Food |
Placebo food (a single time intake) > 2-week washout > Treatment food (a single time intake)
20 | years-old | <= |
75 | years-old | >= |
Male
(1) Healthy male subjects aged from 20 to 75 years old
(2) Subjects who voluntary participate in the clinical trial and provide consent form
(3) Subjects who can maintain a consent daily lifestyle during the study period
(4) 15 subjects with normal high blood glucose or large daily blood glucose fluctuations determined by venous blood collection analysis data after eating 200 g of cooked rice and continuous glucose monitor data
(5) Subjects who are approved to participate by the medical doctor
(1) Subjects who suffer from serious diseases (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or mental disorders
(2) Subjects with a history of serious diseases (diabetes, heart disease, liver disease, renal disease, cancer, etc.) in the past
(3) Subjects who donated more than 200 mL of blood in the past month or more than 400 mL of blood within 3 months.
(4) Subjects who have experienced poor mood or deterioration of physical condition due to blood collection in the past, or have been told that blood collection is difficult due to narrow blood vessels.
(5) Subjects who have severe anemia symptoms
(6) Subjects who are unable to maintain their daily lifestyle due to significant changes in diet and physical activity
(7) Subjects with possible food or drug allergies to the test food
(8) Subjects who regularly consume specific health foods and dietary supplements and cannot discontinue their intake during the examination period.
Others who have been deemed ineligible to participate in this clinical trial by the responsible physician.
15
1st name | Keiko |
Middle name | |
Last name | Kamachi |
Kagawa Nutrition University
Nutrition Clinic
170-8481
Nutrition Clinic, Kagawa Nutrition University, Komagome, Toshima-ku, Tokyo, 170-8481, Japan.
03-3918-6181
kamachi@eiyo.ac.jp
1st name | Tatsuo |
Middle name | |
Last name | Uetake |
CXwellness, Inc.
Representative Director
173-0004
2-63-9-401 Itabashi, Itabashi-ku, Tokyo, Japan
03-6915-5507
uetake@cx-wellness.com
Nutrition clinic, Kagawa Nutrition University
NARO Bio-oriented Technology Research Advancement Institution
Japanese Governmental office
The Human Research Ethics Committee of Kagawa Nutrition University
3-9-21, Chiyoda, Sakado, Saitama, Japan
049-289-6041
kenshien@eiyo.ac.jp
NO
2024 | Year | 02 | Month | 03 | Day |
Unpublished
Completed
2024 | Year | 01 | Month | 10 | Day |
2024 | Year | 01 | Month | 17 | Day |
2024 | Year | 01 | Month | 18 | Day |
2024 | Year | 02 | Month | 28 | Day |
2024 | Year | 01 | Month | 31 | Day |
2024 | Year | 07 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061053